Drug Interactions between SMZ-TMP DS and tovorafenib
This report displays the potential drug interactions for the following 2 drugs:
- SMZ-TMP DS (sulfamethoxazole/trimethoprim)
- tovorafenib
Interactions between your drugs
trimethoprim tovorafenib
Applies to: SMZ-TMP DS (sulfamethoxazole / trimethoprim) and tovorafenib
Trimethoprim may increase the blood levels and effects of tovorafenib. This can increase the risk of side effects such as bleeding problems, skin reactions, including sensitivity to sunlight, liver problems, and slowed growth in children. Talk to your doctor if you have any questions or concerns. Let your doctor know immediately if you develop side effects including coughing up blood or blood clots or red or black stools that look like tar, new or worsening skin reactions, or fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
sulfamethoxazole food
Applies to: SMZ-TMP DS (sulfamethoxazole / trimethoprim)
Ask your doctor before using sulfamethoxazole together with ethanol (alcohol). Contact your doctor if you experience unpleasant side effects such as fast heartbeats, warmth or redness under your skin, tingly feeling, nausea, or vomiting. If you experience these side effects, you may need to avoid ethanol (alcohol) while taking sulfamethoxazole. You should check your food and medicine labels to see if these products contain ethanol (alcohol). It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.